-
821
Erratum to “From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution”
Published 2018-01-01Get full text
Article -
822
-
823
-
824
Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy
Published 2014-01-01Get full text
Article -
825
OMERACT GCA phantom project: validation of a 3D-printed ultrasound training phantom for diagnosis of giant cell arteritis
Published 2025-02-01“…This study tested the reliability of ultrasonography findings and measurements of the intima-media thickness (IMT) among ultrasonography experts by using phantoms of the axillary (AA) and temporal arteries (TA) created with high-resolution 3D printing.Methods Twenty-eight participants from 12 European countries received eight sets of phantoms of the AA and the superficial TA (including common, frontal and parietal branches), which were examined in a blinded fashion according to a predefined protocol and evaluated based on Outcome Measures in Rheumatology (OMERACT) GCA ultrasound definitions. Due to difficulties with the delineation of the intima-media complex, the parietal branch of the phantoms was modified, and a second round was conducted. …”
Get full text
Article -
826
-
827
-
828
-
829
-
830
-
831
-
832
T Regulatory and T Helper 17 Cells in Primary Sjögren’s Syndrome: Facts and Perspectives
Published 2015-01-01Get full text
Article -
833
-
834
-
835
Reliability of the OMERACT Giant cell arteritis Ultrasonography Score (OGUS): results of a patient-based exercise involving experts and non-experts in vascular ultrasonography
Published 2025-01-01“…Objective To test the reliability of the Outcome Measures in Rheumatology Giant cell arteritis (GCA) Ultrasonography Score (OGUS) and other composite scores in a patient-based exercise involving experts and non-experts in vascular ultrasonography.Methods Six GCA patients were scanned twice (two rounds separated ≥3 hours) by 12 experts and 12 non-experts. …”
Get full text
Article -
836
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases
Published 2025-01-01“…This study aimed to investigate the symptom pattern of common viral infections in patients with IMID and compare it with controls without IMIDs.Design A cross-sectional study conducted between 1 February and 30 April 2020, using a questionnaire.Setting Seven tertiary regional care centers in Germany, which specialised in the care of patients with IMID (namely, in gastroenterology, dermatology, rheumatology and immunology clinical care).Participants One thousand nine hundred nine participants completed the survey (757 patients with IMID; 1152 non-IMID controls).Primary outcome measure The occurrence of 11 common viral illness symptoms within the preceding 3 months in patients with IMID and non-IMID controls.Results Symptom data were clustered, based on number and co-occurrance, into 3 major clusters and 2 subclusters ranked by the average number of symptoms. …”
Get full text
Article -
837
-
838
Efficacy and safety of JAK inhibitors in connective tissue disease-associated interstitial lung disease
Published 2025-01-01Get full text
Article -
839
Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
Published 2024-12-01“…In addition, we studied the impact of the alert in the clinical practice of our Rheumatology department. <b>Results:</b> In this retrospective, observational study, 101 patients were analysed, predominantly women (72.3%), with a mean age of 57.6 years. …”
Get full text
Article -
840
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome
Published 2025-01-01Get full text
Article